289 AVOIDING COSTLY CYTOGENETIC ANALYSIS IN MDS BY USING NEUTROPHIL COUNT AND DYSPLASTIC CHARACTERISTICS AT PERIPHERAL BLOOD EXAMINATION AS A PREDICTIVE MODEL